Nexalin Technology, Inc.
General ticker "NXL" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $13.3M (TTM average)
Nexalin Technology, Inc. does not follow the US Stock Market performance with the rate: -22.8%.
Estimated limits based on current volatility of 9.9%: low 1.95$, high 2.39$
Factors to consider:
- Total employees count: 8 (-42.9%) as of 2025
- China accounted for 63.1% of revenue in the fiscal year ended 2025-12-31
- US accounted for 36.9% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Going concern doubt, Regulatory and compliance, Failure to achieve profitability, Clinical trial failure, Market acceptance
- Current price 88.4% below estimated low
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [39.04$, 118.90$]
- 2025-12-31 to 2026-12-31 estimated range: [20.31$, 67.46$]
Financial Metrics affecting the NXL estimates:
- Positive: with PPE of -3.4 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Negative: -0.92 < Industry inventory ratio change (median), % of -0.88
- Negative: negative Industry operating income (median)
- Negative: 0 < Interest expense per share per price, % of 0.01
Short-term NXL quotes
Long-term NXL plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1.32MM | $0.11MM | $0.17MM |
| Operating Expenses | $3.15MM | $5.81MM | $7.92MM |
| Operating Income | $-1.83MM | $-5.70MM | $-7.75MM |
| Non-Operating Income | $0.14MM | $1.05MM | $0.14MM |
| Interest Expense | $0.06MM | $0.04MM | $0.00MM |
| R&D Expense | $0.00MM | $1.92MM | $1.19MM |
| Income(Loss) | $-1.70MM | $-4.65MM | $-7.61MM |
| Net Income(Loss)* | $-1.70MM | $-4.65MM | $-7.61MM |
| Stockholders Equity | $5.48MM | $3.21MM | $3.68MM |
| Inventory | $0.15MM | $0.16MM | $0.17MM |
| Assets | $7.43MM | $3.63MM | $4.22MM |
| Operating Cash Flow | $-2.22MM | $-3.84MM | $-3.94MM |
| Capital expenditure | $0.00MM | $0.11MM | $0.17MM |
| Investing Cash Flow | $-6.79MM | $4.45MM | $-0.58MM |
| Financing Cash Flow | $8.51MM | $-0.20MM | $4.52MM |
| Earnings Per Share** | $-6.99 | $-18.96 | $-24.78 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.